ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,912Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 25

$484K Total Retail Price of All Prescriptions

Rank: 2 out of 25

298 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

15% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,732 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 462 404 1 3
AMLODIPINE BESYLATE 397 367 2 2
FUROSEMIDE 381 323 3 7
ALLOPURINOL 214 190 4 41
PANTOPRAZOLE SODIUM 198 192 5 18
LISINOPRIL 187 166 6 1
LEVOTHYROXINE SODIUM 182 161 7 5
CITALOPRAM HBR 179 156 8 23
METOPROLOL TARTRATE 176 176 9 9
DONEPEZIL HCL 153 149 10 27
CLOPIDOGREL 149 137 11 37
RAMIPRIL 149 127 11 54
ATORVASTATIN CALCIUM 138 127 13 14
OMEPRAZOLE 131 104 14 15
RISPERIDONE 131 125 14 35
METOPROLOL SUCCINATE 128 115 16 12
POTASSIUM CHLORIDE 118 91 17 28
HYDROCHLOROTHIAZIDE 104 73 18 11
GLYBURIDE-METFORMIN HCL 101 83 R 19 70
ENALAPRIL MALEATE 100 81 20 50
KLOR-CON 10 98 86 21 71
MIRTAZAPINE 88 88 22 24
AZITHROMYCIN 83 70 23 34
WARFARIN SODIUM 82 68 24 10
HYDROCODONE-ACETAMINOPHEN 82 67 S3 24 19
PRAVASTATIN SODIUM 81 73 26 6
CIPROFLOXACIN HCL 77 69 27 78
VENLAFAXINE HCL ER 76 66 28 79
LOVASTATIN 74 73 29 57
ALENDRONATE SODIUM 74 74 29 36
PLAVIX 73 69 31 84
TRICOR 72 64 32 86
ZOLPIDEM TARTRATE 72 62 32 20
CARVEDILOL 69 61 34 56
LOSARTAN POTASSIUM 66 39 35 29
IBUPROFEN 66 53 35 32
RANITIDINE HCL 62 51 37 16
GLIMEPIRIDE 62 56 37 59
VERAPAMIL ER 60 46 39 96
MEGESTROL ACETATE 59 59 R 40 99
ATENOLOL 59 55 40 38
FLUTICASONE PROPIONATE 59 57 40 66
DIVALPROEX SODIUM 57 57 43 39
MELOXICAM 56 41 44 102
ISOSORBIDE MONONITRATE ER 56 51 44 102
LEVOFLOXACIN 55 48 46 62
BENAZEPRIL HCL 55 46 46 107
FENOFIBRATE 54 39 48 108
GABAPENTIN 54 51 48 30
AMLODIPINE BESYLATE-BENAZEPRIL 54 31 48 67
AMOXICILLIN 54 38 48 51
METFORMIN HCL 51 47 52 8
TAMSULOSIN HCL 50 50 53 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.